Long‑Read Sequencing Services Market Report 2026

Long‑Read Sequencing Services Market Overview

• Long‑Read Sequencing Services market size has reached to $1.18 billion in 2025 • Expected to grow to $2.79 billion in 2030 at a compound annual growth rate (CAGR) of 18.6% • Growth Driver: Growing Prevalence Of Genetic Disorders Fueling The Growth Of The Market Due To Rising Diagnostic Advancements And Increasing Awareness • Market Trend: Advancements in Single-Cell Long-Read Sequencing For Genomic Resolution • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Long‑Read Sequencing Services Market?

Long-read sequencing services refer to a specialized genomics service that provides high-resolution DNA or RNA sequence data by reading long, continuous stretches of nucleotides. These services enable more accurate genome assemblies, detection of structural variations, and analysis of complex genomic regions. These are used to provide deeper insights into genetic makeup, disease mechanisms, and microbial diversity, supporting research, clinical diagnostics, and biopharmaceutical development. The main service types of long‑read sequencing services are whole genome sequencing, targeted sequencing, de novo sequencing, and others. Whole genome sequencing in long-read sequencing services is the process of determining the complete DNA sequence of an organism’s genome in a single, continuous read format, enabling comprehensive analysis of structural variants and complex regions. The technologies utilized include single-molecule real-time sequencing, nanopore sequencing, and others, and are applied in clinical diagnostics, genomic research, oncology, rare disease detection, and others, serving end users such as academic and research institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and others.

What Is The Long‑Read Sequencing Services Market Growth Forecast?

The long‑read sequencing services market size is expected to see rapid growth in the next few years. It will grow to $2.79 billion in 2030 at a compound annual growth rate (CAGR) of 18.6%. The growth in the forecast period can be attributed to increasing clinical adoption of long-read sequencing, rising investments in population genomics, expansion of precision oncology research, growing demand for de novo genome assembly, integration of ai-based genomic interpretation. Major trends in the forecast period include increasing demand for structural variant analysis services, rising adoption of nanopore sequencing platforms, growing use of long-read sequencing in rare disease research, expansion of clinical-grade long-read sequencing services, enhanced focus on comprehensive genome assembly.

Global Long‑Read Sequencing Services Market Segmentation

1) By Service Type: Whole Genome Sequencing, Targeted Sequencing, De Novo Sequencing, Other Services 2) By Technology: Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Other Technologies 3) By Application: Clinical Diagnostics, Genomic Research, Oncology, Rare Disease Detection, Other Applications 4) By End User: Academic And Research Institutes, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End-Users Subsegments: 1) By Whole Genome Sequencing: Complete Genome Mapping, Comprehensive Variant Detection, Structural Variation Analysis, Comparative Genomics 2) By Targeted Sequencing: Gene Panel Sequencing, Exome Sequencing, Transcriptome Sequencing, Custom Target Region Sequencing 3) By De Novo Sequencing: Novel Genome Assembly, Structural Variant Characterization, Complex Genome Reconstruction, Non-Model Organism Sequencing 4) By Other Services: Data Analysis And Interpretation, Library Preparation Services, Bioinformatics Support Services, Validation And Quality Control Services

What Is The Driver Of The Long‑Read Sequencing Services Market?

The growing prevalence of genetic disorders is expected to propel the growth of the long-read sequencing services market going forward. Genetic diseases are disorders caused by changes or mutations in DNA, which can be inherited or occur spontaneously, affecting health, development, or body functions. The rising prevalence of genetic diseases is due to increased awareness and advancements in diagnostic technologies, as these enable earlier and more accurate detection of previously undiagnosed conditions. Long-read sequencing services support genetic disorder management by providing highly accurate, long-range genomic data, enabling precise detection of structural variants and complex mutations. For instance, in April 2024, according to the National Institutes of Health (NIH), a US-based government’s premier biomedical research agency, An estimated 6.9 million Americans aged 65 and older are currently living with Alzheimer’s dementia, and this figure is projected to nearly double to 13.8 million by 2060. Therefore, the growing prevalence of genetic disorders is driving the growth of the long-read sequencing services market.

Key Players In The Global Long‑Read Sequencing Services Market

Major companies operating in the long‑read sequencing services market are Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., GENEWIZ Inc., Macrogen Inc., Novogene Co. Ltd., DNAnexus Inc., Zymo Research Corp., CD Genomics Inc., Genotypic Technology Pvt. Ltd., Plasmidsaurus Inc., BaseClear B.V., GrandOmics Biosciences Co. Ltd., Arima Genomics Inc., Wuhan Benagen Technology Co. Ltd.

Global Long‑Read Sequencing Services Market Trends and Insights

Major companies operating in the long-read sequencing services market are focusing on developing innovative solutions, such as primary template directed amplification (PTA), which allows for high-fidelity uniform whole-genome amplification from single cells by enabling sensitive detection of single-nucleotide variants (SNVs). Primary template-directed amplification is a proprietary whole-genome amplification technique designed to accurately and uniformly amplify deoxyribonucleic acid (DNA) from ultra-low input samples by minimizing errors and preserving the original deoxyribonucleic acid (DNA) sequence. For instance, in October 2025, BioSkryb Genomics, Inc., a US-based genomics company specializing in long-read sequencing technologies, launched the ResolveSEQ LongRead Early Access Program, a cutting-edge single-cell whole-genome long-read sequencing platform that integrates primary template-directed amplification (PTA) with long-read library preparation to deliver high-coverage, uniform amplification from individual cells. Additionally, the platform enables sensitive detection of single-nucleotide variants (SNVs) and repeat expansions while providing haplotype phasing at single-cell resolution.

What Are Latest Mergers And Acquisitions In The Long‑Read Sequencing Services Market?

In March 2024, Clinical Microbiomics, a Denmark-based microbiome science company specializing in multi-omics and microbiome research services, acquired DNASense Anpartsselskab for an undisclosed amount. Through this acquisition, Clinical Microbiomics aims to expand its capabilities in long-read deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequencing, particularly in advanced microbial community analysis, by integrating DNASense’s cutting-edge long-read sequencing technologies and bioinformatics expertise, thereby enhancing the accuracy and depth of its microbiome services. DNASense Anpartsselskab is a Denmark-based biotechnology company specializing in long-read deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequencing technologies and associated bioinformatics.

Regional Outlook

North America was the largest region in the long‑read sequencing services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the long‑read sequencing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the long‑read sequencing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Long‑Read Sequencing Services Market?

The long-read sequencing services market includes revenues earned by entities through target enrichment, metagenomic sequencing, epigenetic modification analysis, microbial genome sequencing, and human leukocyte antigen (HLA) typing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Long-Read Sequencing Services Market Report 2026?

The long-read sequencing services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the long-read sequencing services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.